Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight [Yahoo! Finance]
DiaMedica Therapeutics Inc. (DMAC)
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
of symptoms, advances in acute stroke care, and a robust pipeline of potential candidates such as lenzocimab (Acticor Biotech), DM199 (DiaMedica Therapeutics), milvexian (BMS-986177) (Bristol Myers Squibb and Janssen Pharmaceuticals), BB-031 (Basking Biosciences) in the 7MM, according to DelveInsight. New York, USA, March 02, 2026 (GLOBE NEWSWIRE) -- Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight The growth of the acute ischemic stroke market is expected to be driven primarily by increased awareness of symptoms, advances in acute stroke care, and a robust pipeline of potential candidates such as lenzocimab (Acticor Biotech), DM199 (DiaMedica Therapeutics), milvexian (BMS-986177) (Bristol Myers Squibb and Janssen Pharmaceuticals), BB-031 (Basking Biosciences) in the 7MM, according to DelveInsight. DelveInsight's Acute Ischemic Stroke Market Insights report includes a comprehe
Show less
Read more
Impact Snapshot
Event Time:
DMAC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DMAC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DMAC alerts
High impacting DiaMedica Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DMAC
News
- DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]Yahoo! Finance
- DiaMedica Therapeutics to Participate in Upcoming March Investor ConferencesBusiness Wire
- DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- DiaMedica Therapeutics (NASDAQ:DMAC) had its "buy" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA [Yahoo! Finance]Yahoo! Finance
DMAC
Earnings
- 11/12/25 - Miss
DMAC
Analyst Actions
- 1/5/26 - Lake Street Capital
DMAC
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- 2/6/26 - Form SCHEDULE
- DMAC's page on the SEC website